At first glance a serotonin reuptake inhibitor makes little sense for the treatment of Covid. What would just increased neuron transmittal have to do with reducing the effects of Covid?

This is what our favorite doctor at our favorite hospital in Brazil has to say about it -

Quote:

---

In a comment published in the Lancet Global Health the same day as the study, Otavio Berwanger, a clinical researcher and director of the Academic Research Organization at Hospital Israelita Albert Einstein in Brazil, tempered praise of the research with the conclusion that “the definitive answer regarding the effects of fluvoxamine on individual outcomes such as mortality and hospitalisations still need addressing,” and called “the inconclusive effects on patient-important outcomes such as hospitalisation and mortality” one of the study’s main limitations.
https://www.the-scientist.com/news-opinion/a-...data-69369

---